WFL
Pharmaceuticals, Biotechnology & Life Sciences
Wellfully
- Short interest
- 0.02%
- as of 12 Dec 2022
- Reported shorts
- 94.1K
- Shares on issue
- 382.057M
Wellfully (WFL) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for WFL (last checked 14 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report24 Apr 2024via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report24 Apr 2024via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report24 Apr 2024via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report24 Apr 2024via asx_announcements
- Preliminary Final ReportAnnual Results23 Apr 2024via asx_announcements
- Appendix 4D & 2023 Half Year ReportHalf Year Results8 Apr 2024via asx_announcements
- Annual Report to shareholdersAnnual Report29 Feb 2024via asx_announcements